Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 393

1.

Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.

Alt A, Lammens K, Chiocchini C, Lammens A, Pieck JC, Kuch D, Hopfner KP, Carell T.

Science. 2007 Nov 9;318(5852):967-70.

2.

Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.

Vaisman A, Masutani C, Hanaoka F, Chaney SG.

Biochemistry. 2000 Apr 25;39(16):4575-80.

PMID:
10769112
3.

Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy.

Ummat A, Rechkoblit O, Jain R, Roy Choudhury J, Johnson RE, Silverstein TD, Buku A, Lone S, Prakash L, Prakash S, Aggarwal AK.

Nat Struct Mol Biol. 2012 May 6;19(6):628-32. doi: 10.1038/nsmb.2295.

4.

Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.

Chijiwa S, Masutani C, Hanaoka F, Iwai S, Kuraoka I.

Carcinogenesis. 2010 Mar;31(3):388-93. doi: 10.1093/carcin/bgp316. Epub 2009 Dec 16.

5.

Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.

Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, Chaney SG.

Biochemistry. 2003 Dec 9;42(48):14197-206.

PMID:
14640687
6.

Structural insight into dynamic bypass of the major cisplatin-DNA adduct by Y-family polymerase Dpo4.

Wong JH, Brown JA, Suo Z, Blum P, Nohmi T, Ling H.

EMBO J. 2010 Jun 16;29(12):2059-69. doi: 10.1038/emboj.2010.101. Epub 2010 May 28.

7.

Replication of a cis-syn thymine dimer at atomic resolution.

Ling H, Boudsocq F, Plosky BS, Woodgate R, Yang W.

Nature. 2003 Aug 28;424(6952):1083-7. Epub 2003 Aug 6.

PMID:
12904819
8.

Protein interactions with platinum-DNA adducts: from structure to function.

Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M.

J Inorg Biochem. 2004 Oct;98(10):1551-9.

PMID:
15458816
9.
10.

Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.

Bassett E, Vaisman A, Tropea KA, McCall CM, Masutani C, Hanaoka F, Chaney SG.

DNA Repair (Amst). 2002 Dec 5;1(12):1003-16.

PMID:
12531010
14.

Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.

Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, Chaney SG.

Biochemistry. 2003 Feb 18;42(6):1777-88.

PMID:
12578393
15.

Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity.

McCulloch SD, Kokoska RJ, Masutani C, Iwai S, Hanaoka F, Kunkel TA.

Nature. 2004 Mar 4;428(6978):97-100.

PMID:
14999287
16.

Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass.

Lone S, Townson SA, Uljon SN, Johnson RE, Brahma A, Nair DT, Prakash S, Prakash L, Aggarwal AK.

Mol Cell. 2007 Feb 23;25(4):601-14.

17.

Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin.

Zhao Y, Biertümpfel C, Gregory MT, Hua YJ, Hanaoka F, Yang W.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7269-74. doi: 10.1073/pnas.1202681109. Epub 2012 Apr 23.

18.

Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.

Chaney SG, Campbell SL, Bassett E, Wu Y.

Crit Rev Oncol Hematol. 2005 Jan;53(1):3-11. Review.

PMID:
15607931
19.
20.

Structural basis for the inefficient nucleotide incorporation opposite cisplatin-DNA lesion by human DNA polymerase β.

Koag MC, Lai L, Lee S.

J Biol Chem. 2014 Nov 7;289(45):31341-8. doi: 10.1074/jbc.M114.605451. Epub 2014 Sep 18.

Items per page

Supplemental Content

Write to the Help Desk